<DOC>
	<DOCNO>NCT00006166</DOCNO>
	<brief_summary>The NASTRA Clinical Trial multi-center , randomize , control clinical trial design determine treatment transjugular intrahepatic portasystemic shunt ( TIPS ) superior high volume paracentesis ( total paracentesis , TP ) treatment refractory ascites due cirrhosis . Only patient clinically tense symptomatic ascites ( shortness breath , umbilical hernia , abdominal pain and/or distension , and/or limitation activity ) either diuretic-resistant ascites diuretic-intractable ascites study .</brief_summary>
	<brief_title>North American Study Treatment Refractory Ascites ( NASTRA )</brief_title>
	<detailed_description />
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Ascites</mesh_term>
	<criteria>Cirrhosis document biopsy clinical/laboratory parameter WITH Tense symptomatic ascites need paracentesis ( 10 L ) within last 2 month AND Failure medical therapy define inability lose least 3.3 lbs/week maximum dos diuretic diuretic related complication ( severe hyponatremia , hypercalcemia , azotemia encephalopathy ) Causes ascites cirrhosis portal hypertension Terminal liver failure Portal vein thrombosis Congestive heart failure Acute renal failure Active encephalopathy Alcoholic hepatitis Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>refractory ascites</keyword>
	<keyword>paracenteses</keyword>
</DOC>